As of 30 Sep 2025, 25 institutional investors reported holding 1,717,330 shares of Lexaria Bioscience Corp. - COM NEW (LEXX).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 105,500 | $65,094 | +$15,835 | $0.62 | 1 |
| 2025 Q3 | 1,717,330 | $1,634,751 | -$453,747 | $0.95 | 25 |
| 2025 Q2 | 2,297,450 | $1,999,388 | +$851,078 | $0.87 | 21 |
| 2025 Q1 | 1,239,756 | $2,119,588 | -$537,170 | $1.71 | 22 |
| 2024 Q4 | 1,439,571 | $3,022,892 | +$637,194 | $2.10 | 25 |
| 2024 Q3 | 1,066,674 | $3,252,819 | -$2,740,929 | $3.05 | 27 |
| 2024 Q2 | 2,057,835 | $5,720,708 | +$3,236,556 | $2.78 | 28 |
| 2024 Q1 | 888,794 | $3,225,972 | -$432,702 | $3.63 | 25 |
| 2023 Q4 | 1,195,589 | $1,494,550 | -$493,306 | $1.25 | 19 |
| 2023 Q3 | 1,771,138 | $1,770,635 | +$883,098 | $1.00 | 14 |
| 2023 Q2 | 892,281 | $651,351 | +$101,930 | $0.73 | 12 |
| 2023 Q1 | 678,680 | $1,846,092 | -$43,432 | $2.72 | 15 |
| 2022 Q4 | 689,631 | $1,693,524 | +$51,841 | $2.46 | 13 |
| 2022 Q3 | 1,000 | $2,000 | -$99,999 | $2.00 | 1 |
| 2022 Q2 | 559,534 | $1,666,000 | +$262,916 | $2.98 | 14 |
| 2022 Q1 | 470,050 | $1,402,000 | +$54,740 | $3.29 | 9 |
| 2021 Q4 | 454,877 | $1,841,000 | -$14,992 | $4.04 | 9 |
| 2021 Q3 | 451,978 | $2,829,000 | +$202,893 | $6.26 | 9 |
| 2021 Q2 | 417,340 | $2,926,000 | +$714,527 | $7.01 | 9 |
| 2021 Q1 | 318,001 | $1,785,000 | +$1,785,008 | $5.67 | 7 |